Bellicum Logo.jpg
Bellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy Summit
March 27, 2019 07:30 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, March 27, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...